Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

ClinicalTrials.gov ID: NCT01201057

Public ClinicalTrials.gov record NCT01201057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Multi-center, Randomized, Placebo Controlled, Dose-ranging Study to Determine the Efficacy and Safety of SPL7013 Gel (VivaGel®) Administered Vaginally in the Treatment of Bacterial Vaginosis

Study identification

NCT ID
NCT01201057
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Starpharma Pty Ltd
Industry
Enrollment
132 participants

Conditions and interventions

Interventions

  • 0.5% SPL7013 Gel Drug
  • 1.0% SPL7013 Gel Drug
  • 3.0% SPL7013 Gel Drug
  • Placebo Gel Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Feb 28, 2011
Completion
Apr 30, 2011
Last update posted
Jun 5, 2019

2010 – 2011

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Precision Trials Phoenix Arizona 85032
Downtown Women's Health Care Denver Colorado 80218
Clinical Research Center of Nevada Las Vegas Nevada 89104
Bexar Clinical Trials, LLC Irving Texas 75061
Tidewater Clinical Research Inc Virginia Beach Virginia 23456

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01201057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01201057 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →